Determination of Diabetes and Dyslipidemia Goals in the Management of Diabetes | Chapter 6 | New Frontiers in Medicine and Medical Research Vol. 14
Diabetes Type I and Type II have an increased risk of early atherosclerotic CVD, such as CHD and PAD [1], and it is well known that glucose control improves TG levels and cholesterol-lowering has beneficial effects on CVD outcomes in T1DM and T2DM.
Author (S) Details
Rajesh Jain
Diabetes
Prevention Control Project, National Health Mission, India.
Susanne Olejas
World
Diabetes Foundation, Denmark.
Sanjeev Davey
Muzaffarnagar
Medical College, India.
Rachna Jain
Department
of Obstetrics & Gynecology, Jain Hospital, India.
Reza Shoghli
Department
of Cardiology, Azad University of Tehran, Iran.
Mohammad Iqbal
Consultant
Diabetes in Dubai and UK.
Seyed Hoseyn Ahmadi
Tafti
Tehran
Heart Centre, Tehran, Iran.
Siyamak Jalal
hosseini
Tehran
Heart Centre, Tehran, Iran.
View Book :- https://stm.bookpi.org/NFMMR-V14/article/view/3388
Comments
Post a Comment